Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1993 1
1994 3
1995 1
1997 1
1998 1
1999 1
2002 2
2003 2
2008 1
2009 1
2010 2
2011 2
2012 2
2013 3
2014 2
2015 1
2016 8
2017 3
2019 2
2020 2
2021 4
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Middle Ear Carcinoma In Situ"
Page 1
Lymphoepithelial-like carcinomas of the head and neck.
Wenig BM. Wenig BM. Semin Diagn Pathol. 2015 Jan;32(1):74-86. doi: 10.1053/j.semdp.2014.12.004. Epub 2014 Dec 19. Semin Diagn Pathol. 2015. PMID: 25804344 Review.
However, LELC may arise in other sites including the oropharynx (tonsils, base of tongue), sinonasal tract, larynx, and middle ear/temporal bone. Unlike the nonkeratinizing undifferentiated type of NPC which is etiologically linked to Epstein-Barr virus (EBV), LELCs …
However, LELC may arise in other sites including the oropharynx (tonsils, base of tongue), sinonasal tract, larynx, and middle ear …
Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.
Withrow DR, Morton LM, Curtis RE, Schonfeld SJ, Berrington de González A. Withrow DR, et al. Breast Cancer Res Treat. 2017 Nov;166(1):299-306. doi: 10.1007/s10549-017-4410-6. Epub 2017 Jul 25. Breast Cancer Res Treat. 2017. PMID: 28744752 Free PMC article.
PURPOSE: Radiotherapy for ductal carcinoma (DCIS) is increasing, but the risks and benefits of the treatment remain uncertain. ...We estimated relative risks (RRs), attributable risks (AR), and excess absolute risks (EAR) of second non-breast cancers associated with …
PURPOSE: Radiotherapy for ductal carcinoma (DCIS) is increasing, but the risks and benefits of the treatment remain uncertain. ...We …
In Situ Preservation of Parathyroid Gland With Vasculature for Papillary Thyroid Carcinoma Is Associated With Higher PTH Levels After Total Thyroidectomy.
Yin C, Song B, Zheng W, Li X, Zhao H, Wang X. Yin C, et al. Ear Nose Throat J. 2022 Feb;101(2):95-104. doi: 10.1177/01455613211039807. Epub 2021 Sep 2. Ear Nose Throat J. 2022. PMID: 34472380 Free article.
PURPOSE: To evaluate the impact of parathyroid gland vasculature preservation in-situ technique (PGVPIST) on postoperative parathyroid hormone (PTH) and calcium plasma levels in thyroid patients undergoing total thyroidectomy for papillary thyroid carcinoma (PTC). . …
PURPOSE: To evaluate the impact of parathyroid gland vasculature preservation in-situ technique (PGVPIST) on postoperative parathyroi …
Photodynamic therapy and the treatment of head and neck neoplasia.
Biel MA. Biel MA. Laryngoscope. 1998 Sep;108(9):1259-68. doi: 10.1097/00005537-199809000-00001. Laryngoscope. 1998. PMID: 9738739 Review.
Only one patient has had recurrence to date, with a cure rate to 79-month follow-up of 95%. Twenty-nine patients with carcinoma in situ and T1 recurrent squamous cell carcinomas of the oral cavity and tongue were treated. ...CONCLUSIONS: Photodynamic therapy …
Only one patient has had recurrence to date, with a cure rate to 79-month follow-up of 95%. Twenty-nine patients with carcinoma in …
Hyperbaric Oxygen Therapy for Threatened Nipple-Sparing Mastectomy Flaps: An Adjunct for Flap Salvage.
Nasr HY, Rifkin WJ, Muller JN, Chiu ES. Nasr HY, et al. Ann Plast Surg. 2023 May 1;90(5S Suppl 2):S125-S129. doi: 10.1097/SAP.0000000000003441. Epub 2023 Mar 8. Ann Plast Surg. 2023. PMID: 36913565 Review.
The mean SD age was 46.7 10.4 years, and mean SD follow-up time was 36.5 25.6 days. Indications for NSM included invasive cancer (41.2%), carcinoma in situ (29.4%), and breast cancer prophylaxis (29.4%). Initial reconstruction included tissue-expander placeme …
The mean SD age was 46.7 10.4 years, and mean SD follow-up time was 36.5 25.6 days. Indications for NSM included invasive cancer (41.2%), …
Gender differences in tumor and patient characteristics in those undergoing Mohs surgery.
Lee KC, Higgins HW 2nd, Linden O, Cruz AP. Lee KC, et al. Dermatol Surg. 2014 Jun;40(6):686-90. doi: 10.1111/dsu.0000000000000020. Dermatol Surg. 2014. PMID: 24852474

RESULTS: There was a 1.5:1 male predominance in the presentation of basal cell carcinoma (BCC) for MMS. However, BCC comprised 72% of tumors in women compared with 63% in men. ...Superficial BCCs were more common in women (p < .001). Women had fewer squamous cell car

…
RESULTS: There was a 1.5:1 male predominance in the presentation of basal cell carcinoma (BCC) for MMS. However, BCC comprised 72% of …
Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases.
Yousef YA, Finger PT. Yousef YA, et al. Ophthalmology. 2012 Feb;119(2):233-40. doi: 10.1016/j.ophtha.2011.08.005. Epub 2011 Dec 20. Ophthalmology. 2012. PMID: 22189448
PARTICIPANTS: One hundred one eyes of 99 patients with squamous conjunctival dysplasia, carcinoma in situ, or squamous cell carcinoma. METHODS: Review of the medical records, pathology reports, and color photographs. ...None of the tumors defined histo …
PARTICIPANTS: One hundred one eyes of 99 patients with squamous conjunctival dysplasia, carcinoma in situ, or squamous …
Voice Outcomes After Radiation for Early-Stage Laryngeal Cancer.
Naunheim MR, Garneau J, Park C, Carroll L, Goldberg L, Woo P. Naunheim MR, et al. J Voice. 2020 May;34(3):460-464. doi: 10.1016/j.jvoice.2018.11.007. Epub 2019 Jan 2. J Voice. 2020. PMID: 30611594
METHODS: All patients treated with radiation for early-stage laryngeal carcinoma (in situ, T1, or T2) by a single surgeon from 2011-2018 were reviewed. ...The average follow-up from time of treatment was 9.6 years (range 3.0-20.3 years), and the average time …
METHODS: All patients treated with radiation for early-stage laryngeal carcinoma (in situ, T1, or T2) by a single surge …
Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature.
Raslan WF, Barnes L, Krause JR, Contis L, Killeen R, Kapadia SB. Raslan WF, et al. Am J Otolaryngol. 1994 May-Jun;15(3):204-11. doi: 10.1016/0196-0709(94)90006-x. Am J Otolaryngol. 1994. PMID: 8024109 Review.
INTRODUCTION: We describe the clinicopathologic and flow cytometric features of 10 cases of basaloid squamous cell carcinoma (BSCC) of the head and neck to determine if DNA ploidy is a useful prognostic indicator. ...Histologically, BSCC showed a biphasic pattern with basa …
INTRODUCTION: We describe the clinicopathologic and flow cytometric features of 10 cases of basaloid squamous cell carcinoma (BSCC) o …
Topical oral cavity chemoprophylaxis using isotretinoin rinse: A 15-year experience.
Kadakia S, Badhey A, Milam M, Lee T, Ducic Y. Kadakia S, et al. Laryngoscope. 2017 Jul;127(7):1595-1599. doi: 10.1002/lary.26463. Epub 2016 Dec 21. Laryngoscope. 2017. PMID: 28000225 Clinical Trial.
OBJECTIVES/HYPOTHESIS: To determine the utility of isotretinoin oral rinses as a method of chemoprevention for recurrent oral cavity squamous cell carcinoma (SCC), carcinoma in situ, and dysplasia. STUDY DESIGN: Retrospective cohort study. ...CONCLUSIO …
OBJECTIVES/HYPOTHESIS: To determine the utility of isotretinoin oral rinses as a method of chemoprevention for recurrent oral cavity squamou …
42 results